Assessing the application of human-centered design to translational research.
Team science
collaboration
creativity
human centered design
inclusion
innovation
Journal
Journal of clinical and translational science
ISSN: 2059-8661
Titre abrégé: J Clin Transl Sci
Pays: England
ID NLM: 101689953
Informations de publication
Date de publication:
2021
2021
Historique:
received:
27
01
2021
revised:
06
05
2021
accepted:
15
05
2021
entrez:
9
8
2021
pubmed:
10
8
2021
medline:
10
8
2021
Statut:
epublish
Résumé
Human-centered design (HCD) training offers the potential to improve both team processes and products. However, the use of HCD to improve the quality of team science is a relatively recent application, and its benefits and challenges have not been rigorously evaluated. We conducted a qualitative study with health sciences researchers trained in HCD methods. We aimed to determine how researchers applied HCD methods and perceived the benefits and barriers to using HCD on research teams. We conducted 1-hour, semi-structured interviews with trainees from three training cohorts. Interviews focused on perceptions of the training, subsequent uses of HCD, barriers and facilitators, and perceptions of the utility of HCD to science teams. Data analysis was conducted using Braun and Clarke's process for thematic analysis. We interviewed nine faculty and nine staff trained in HCD methods and identified four themes encompassing HCD use, benefits, challenges, and tensions between HCD approaches and academic culture. Trainees found HCD relevant to research teams for stakeholder engagement, research design, project planning, meeting facilitation, and team management. They also described benefits of HCD in five distinct areas: creativity, egalitarianism, structure, efficiency, and visibility. Our data suggest that HCD has the potential to help researchers work more inclusively and collaboratively on interdisciplinary teams and generate more innovative and impactful science. The application of HCD methods is not without challenges; however, we believe these challenges can be overcome with institutional investment.
Identifiants
pubmed: 34367675
doi: 10.1017/cts.2021.794
pii: S2059866121007949
pmc: PMC8327548
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e130Informations de copyright
© The Association for Clinical and Translational Science 2021.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Euro Surveill. 2015 Mar 26;20(12):
pubmed: 25846493
Hum Factors. 2008 Jun;50(3):540-7
pubmed: 18689065
Sci Transl Med. 2010 Mar 10;2(22):22cm9
pubmed: 20374998
Clin Transl Sci. 2011 Oct;4(5):363-8
pubmed: 22029810
Science. 2020 Mar 13;367(6483):1204
pubmed: 32165577
Int J Behav Nutr Phys Act. 2016 Aug 08;13:90
pubmed: 27501724
Science. 2007 May 18;316(5827):1036-9
pubmed: 17431139
JAMA. 2020 Dec 15;324(23):2369-2370
pubmed: 33320236
Am Psychol. 2018 May-Jun;73(4):549-562
pubmed: 29792467
J Investig Med. 2012 Jun;60(5):768-75
pubmed: 22525233
Am J Prev Med. 2008 Aug;35(2 Suppl):S77-89
pubmed: 18619407
Prog Community Health Partnersh. 2016 Summer;10(2):311-8
pubmed: 27346778
PLoS One. 2014 Aug 29;9(8):e103205
pubmed: 25170939
PLoS One. 2017 Nov 1;12(11):e0186744
pubmed: 29091935
Am J Prev Med. 2008 Aug;35(2 Suppl):S151-60
pubmed: 18619395
Curr Drug Saf. 2015;10(1):31-40
pubmed: 25859673
J Hosp Infect. 2007 Sep;67(1):9-21
pubmed: 17719685
Am Psychol. 2019 Apr;74(3):278-289
pubmed: 30945891
Health Promot Pract. 2020 Jan;21(1):37-48
pubmed: 31131633
Glob Health Sci Pract. 2016 Jun 27;4(2):336-41
pubmed: 27353625
Am J Prev Med. 2008 Aug;35(2 Suppl):S243-9
pubmed: 18619406
J Clin Transl Sci. 2017 Jun;1(3):160-166
pubmed: 29093966
Inf Technol Dev. 2019 Sep 29;26(3):477-505
pubmed: 32982007
J Ambul Care Manage. 2014 Apr-Jun;37(2):148-54
pubmed: 24594562
Healthc (Amst). 2016 Mar;4(1):11-4
pubmed: 27001093
BMJ Open. 2015 Sep 07;5(9):e007980
pubmed: 26346873
J Surg Res. 2020 Mar;247:163-171
pubmed: 31776023
J Acad Nutr Diet. 2014 Apr;114(4):570-7
pubmed: 24507626